@xconomy.com 4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@techcrunch.com 4 years ago
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that